We’ve been engaged by a promising, Boston area pharmaceutical company to find the person who will lead their discovery/investigative toxicology function. The position reports to the company’s SVP of Nonclinical Development, a well respected leader in the field.

The person hired for this role will be the company’s first safety assessment program head and thus, responsible for establishing best practices and resources in early phase toxicology and portfolio de-risking. He/She will actively participate on project teams from the earliest discovery efforts through Phase I development. The needed internal and external resources will be planned and overseen by this individual.

Important credentials include a PhD or DVM and several years of pharmaceutical industry experience with investigative/discovery approaches to nonclinical safety. An ability to design new systems and approaches and contribute to overall safety assessment strategies is important. The ideal candidate would have small molecule and RNA biology experience.

Search assignment #1421